A meta-analysis on the preadmission use of DPP-4 inhibitors and risk of a fatal or severe course of illness in patients with COVID-19

Detalles Bibliográficos
Autores principales: Kow, Chia Siang, Hasan, Syed Shahzad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Société française de pharmacologie et de thérapeutique. Published by Elsevier Masson SAS. 2021
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7834767/
https://www.ncbi.nlm.nih.gov/pubmed/33423787
http://dx.doi.org/10.1016/j.therap.2020.12.015

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7834767/
https://www.ncbi.nlm.nih.gov/pubmed/33423787
http://dx.doi.org/10.1016/j.therap.2020.12.015

Ejemplares similares